{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:22:52Z","timestamp":1791494572050,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"am","delay-in-days":321,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["2R01AI132413"],"award-info":[{"award-number":["2R01AI132413"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020302","name":"Materials Research Science and Engineering Center, University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["ECCS-2025752"],"award-info":[{"award-number":["ECCS-2025752"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMR-2011924"],"award-info":[{"award-number":["DMR-2011924"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["1 T32 HL 160507-1 A1"],"award-info":[{"award-number":["1 T32 HL 160507-1 A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["DP2 NS111507"],"award-info":[{"award-number":["DP2 NS111507"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jconrel.2025.114030","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T11:57:35Z","timestamp":1752580655000},"page":"114030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Formulation methods for peptide-modified lipid nanoparticles"],"prefix":"10.1016","volume":"385","author":[{"given":"Katelyn","family":"Miyasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangwoo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Carton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Kandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester J.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114030_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114030_bb0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s12276-022-00757-5","article-title":"RNA therapy: rich history, various applications and unlimited future prospects","volume":"54","author":"Kim","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114030_bb0015","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/acs.molpharmaceut.1c00916","article-title":"Lipid-nanoparticle-based delivery of CRISPR\/Cas9 genome-editing components","volume":"19","author":"Kazemian","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.114030_bb0020","article-title":"Comprehensive analysis of lipid nanoparticle formulation and preparation for RNA delivery","volume":"8","author":"Haque","year":"2024","journal-title":"Int. J. Pharm. X"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114030_bb0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/d41573-023-00002-2","article-title":"The landscape for lipid-nanoparticle-based genomic medicines","volume":"22","author":"Verma","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114030_bb0030","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.114030_bb0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","article-title":"Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA","volume":"235","author":"Chen","year":"2016","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114030_bb0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11095-022-03166-5","article-title":"Biodistribution and non-linear gene expression of mRNA LNPs affected by delivery route and particle size","volume":"39","author":"Di","year":"2022","journal-title":"Pharm. Res."},{"issue":"52","key":"10.1016\/j.jconrel.2025.114030_bb0045","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.jconrel.2025.114030_bb0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114030_bb0055","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1016\/j.ymthe.2021.06.004","article-title":"Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs","volume":"29","author":"Tomb\u00e1cz","year":"2021","journal-title":"Mol. Ther."},{"issue":"6576","key":"10.1016\/j.jconrel.2025.114030_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114030_bb0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2022.06.052","article-title":"Targeted delivery of lipid nanoparticle to lymphatic endothelial cells via anti-Podoplanin antibody","volume":"349","author":"Sakurai","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114030_bb0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2018.10.015","article-title":"PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake","volume":"291","author":"Parhiz","year":"2018","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jconrel.2025.114030_bb0075","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3390\/pharmaceutics15061648","article-title":"Targeting peptides: the new generation of targeted drug delivery systems","volume":"15","author":"Todaro","year":"2023","journal-title":"Pharmaceutics"},{"issue":"28","key":"10.1016\/j.jconrel.2025.114030_bb0080","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1002\/adma.201200454","article-title":"Peptides as targeting elements and tissue penetration devices for nanoparticles","volume":"24","author":"Ruoslahti","year":"2012","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.jconrel.2025.114030_bb0085","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3390\/pharmaceutics15061603","article-title":"Increased bone marrow uptake and accumulation of very-late Antigen-4 targeted lipid nanoparticles","volume":"15","author":"Swart","year":"2023","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114030_bb0090","doi-asserted-by":"crossref","first-page":"eadd4623","DOI":"10.1126\/sciadv.add4623","article-title":"Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman Primates","volume":"9","author":"Herrera-Barrera","year":"2023","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.jconrel.2025.114030_bb0095","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1021\/acsnano.0c02633","article-title":"Liver-targeted siRNA lipid nanoparticles treat hepatic cirrhosis by dual Antifibrotic and anti-inflammatory activities","volume":"14","author":"Zhang","year":"2020","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114030_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102375","article-title":"Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles to cystic fibrosis lung epithelia","volume":"35","author":"Soto","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"39","key":"10.1016\/j.jconrel.2025.114030_bb0105","doi-asserted-by":"crossref","first-page":"25397","DOI":"10.1039\/D2RA02771B","article-title":"RGD peptide-based lipids for targeted mRNA delivery and gene editing applications","volume":"12","author":"Qin","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2025.114030_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121741","article-title":"A robust post-insertion method for the preparation of targeted siRNA LNPs","volume":"620","author":"Swart","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114030_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6800","article-title":"RGD peptide in Cancer targeting: benefits, challenges, solutions, and possible integrin\u2013RGD interactions","volume":"13","author":"Javid","year":"2024","journal-title":"Cancer Med."},{"issue":"37","key":"10.1016\/j.jconrel.2025.114030_bb0120","doi-asserted-by":"crossref","first-page":"9496","DOI":"10.1016\/j.biomaterials.2013.09.001","article-title":"CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and Angiogenic blood vessels","volume":"34","author":"Hu","year":"2013","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.jconrel.2025.114030_bb0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11307-006-0043-6","article-title":"In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging","volume":"8","author":"Kelly","year":"2006","journal-title":"Mol. Imaging Biol."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114030_bb0130","doi-asserted-by":"crossref","first-page":"2000196","DOI":"10.1002\/adtp.202000196","article-title":"VCAM-1-targeted gene delivery nanoparticles localize to inflamed endothelial cells and atherosclerotic plaques","volume":"4","author":"Distasio","year":"2021","journal-title":"Adv. Ther."},{"issue":"9","key":"10.1016\/j.jconrel.2025.114030_bb0135","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1021\/acsnano.5b02611","article-title":"Multifunctional nanoparticles facilitate molecular targeting and miRNA delivery to inhibit atherosclerosis in ApoE \u2212\/\u2212 mice","volume":"9","author":"Kheirolomoom","year":"2015","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2025.114030_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2010.08.011","article-title":"RVG peptide tethered bioreducible Polyethylenimine for gene delivery to brain","volume":"155","author":"Son","year":"2011","journal-title":"J. Control. Release"},{"issue":"7149","key":"10.1016\/j.jconrel.2025.114030_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.114030_bb0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.omtm.2023.06.005","article-title":"Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues","volume":"30","author":"Chander","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2025.114030_bb0155","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2012.28","article-title":"Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA","volume":"1","author":"Belliveau","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2025.114030_bb0160","doi-asserted-by":"crossref","DOI":"10.1039\/D2BM01846B","article-title":"Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury","author":"Waggoner","year":"2023","journal-title":"Biomater. Sci."},{"issue":"12","key":"10.1016\/j.jconrel.2025.114030_bb0165","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1021\/jacs.4c18308","article-title":"Lipid-siRNA organization modulates the intracellular dynamics of lipid nanoparticles","volume":"147","author":"Mo","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.jconrel.2025.114030_bb0170","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/mp3002733","article-title":"RGD-based strategies to target alpha(v) Beta(3) integrin in Cancer therapy and diagnosis","volume":"9","author":"Danhier","year":"2012","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114030_bb0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1164\/rccm.201110-1859ED","article-title":"Inflammation and \u03b1 v \u03b2 3 integrin","volume":"185","author":"Ward","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.jconrel.2025.114030_bb0180","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3390\/cancers13071711","article-title":"RGD-binding Integrins revisited: how recently discovered functions and novel synthetic ligands (re-)shape an ever-evolving field","volume":"13","author":"Ludwig","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.jconrel.2025.114030_bb0185","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1021\/acs.bioconjchem.5b00327","article-title":"Radiolabeled cyclic RGD peptide bioconjugates as radiotracers targeting multiple Integrins","volume":"26","author":"Liu","year":"2015","journal-title":"Bioconjug. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114030_bb0190","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1016-8478(23)13157-8","article-title":"Structure and function of RGD peptides derived from Disintegrin proteins","volume":"19","author":"Kim","year":"2005","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.jconrel.2025.114030_bb0195","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3390\/biology10070688","article-title":"Comparison of linear vs. cyclic RGD Pentapeptide interactions with integrin \u0391v\u03b23 by molecular dynamics simulations","volume":"10","author":"Li","year":"2021","journal-title":"Biology"},{"issue":"11","key":"10.1016\/j.jconrel.2025.114030_bb0200","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.biomaterials.2007.12.015","article-title":"Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets","volume":"29","author":"Huang","year":"2008","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jconrel.2025.114030_bb0205","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","article-title":"Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain","volume":"25","author":"Han","year":"2025","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114030_bb0210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/mp200434n","article-title":"Targeting cell surface alpha(v)Beta(3) integrin increases therapeutic efficacies of a Legumain protease-activated Auristatin prodrug","volume":"9","author":"Liu","year":"2012","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114030_bb0215","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114030_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2013.66","article-title":"Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles","volume":"2","author":"Mui","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"5","key":"10.1016\/j.jconrel.2025.114030_bb0225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/protein\/gzh055","article-title":"Novel RGD Lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells","volume":"17","author":"Holig","year":"2004","journal-title":"Protein Eng. Des. Sel."},{"issue":"1","key":"10.1016\/j.jconrel.2025.114030_bb0230","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nn.2467","article-title":"A robust and high-throughput Cre reporting and characterization system for the whole mouse brain","volume":"13","author":"Madisen","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2025.114030_bb0235","first-page":"1037","article-title":"Expression of integrin \u0391v\u03b23 in pig, dog and cattle","volume":"16","author":"Singh","year":"2001","journal-title":"Histol. Histopathol."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2025.114030_bb0240","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0168-3659(03)00240-2","article-title":"Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin","volume":"91","author":"Schiffelers","year":"2003","journal-title":"J. Control. Release"},{"issue":"31","key":"10.1016\/j.jconrel.2025.114030_bb0245","doi-asserted-by":"crossref","first-page":"2303370","DOI":"10.1002\/adma.202303370","article-title":"Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency","volume":"35","author":"Cheng","year":"2023","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2025.114030_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102175","article-title":"Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system","volume":"35","author":"Parhiz","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"7","key":"10.1016\/j.jconrel.2025.114030_bb0255","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925006510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925006510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:25:43Z","timestamp":1778945143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925006510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":51,"alternative-id":["S0168365925006510"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114030","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation methods for peptide-modified lipid nanoparticles","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114030"}}